We are live on ! Find out more
AH

Accretive Health
AH

Delisted

AH was delisted on the 14th of March, 2014.

Back to rankings

3 hedge funds and large institutions have $16.7M invested in Accretive Health in 2014 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

36% less capital invested

Capital invested by funds: $26.1M → $16.7M (-$9.47M)

57% less funds holding

Funds holding: 7 → 3 (-4)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
3
Holders Change
-4
Holders Change %
-57.14%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Neuberger Berman Group
Neuberger Berman Group
New York
+$2.01M
2
PCMI
Paradigm Capital Management Inc
New York
+$1.04M

Top Sellers

Rank Fund Capital Flow
1
BCM
Breithorn Capital Management
New York
-$2.24M
2
ECM
EII Capital Management
New York
-$1.34M
3
Northern Trust
Northern Trust
Illinois
-$154K
4
RMC
Regis Management Company
California
-$62K

AH Hedge Fund Activity: Q4 2014 in Review

3 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Accretive Health (AH) for Q4 2014, worth a combined $16.7M — down 36% from $26.1M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of AH and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Neuberger Berman Group, adding an estimated $2.01M. The largest seller was Breithorn Capital Management, exiting entirely with an estimated $2.24M sold.

  • 3 institutional investors held Accretive Health (AH) as of Q4 2014, down from 7 in Q3 2014.
  • Funds reported $16.7M of Accretive Health stock for Q4 2014, down 36% quarter-over-quarter.
  • 0 funds opened new Accretive Health positions in Q4 2014 and 3 closed out, a net change of -3 holders.
  • The largest Accretive Health buyer in Q4 2014 was Neuberger Berman Group, an estimated $2.01M added.
  • The largest Accretive Health seller in Q4 2014 was Breithorn Capital Management, an estimated $2.24M sold.

Based on aggregated 13F filings for Q4 2014.